Merakris Therapeutics, Inc.
Roger Ilagan, PhD has held several key positions in the field of regenerative medicine and biotechnology. Roger currently serves as the Vice President, Research and Development at Merakris Therapeutics, Inc. Roger's expertise includes overseeing scientific development, establishing research collaborations, and focusing on pulmonary diseases. With a Ph.D. in Cell Biology from Duke University, Roger's extensive experience includes roles in companies like Tavanta Therapeutics, Lung Biotechnology PBC, and United Therapeutics, where Roger managed research initiatives for tissue-engineered organs and gene therapy. Prior to their current role, Roger worked on bioprocess R&D and tissue regeneration at companies like LifeCell and Tengion.